"In addition to being one of the leading voices in the life sciences and patent industries, Sherry is also a cancer survivor. Among other things, we discuss numerous patent system challenges facing innovator drug companies, the downward pressure generic drugs place on the industry and leading to important drugs becoming unavailable, the role of Pharmacy Benefit Managers (PBMs) with respect to significantly raising the cost of drugs for Americans, and policy influences and legislation on Capitol Hill."
"Sherry opened up about her battle with breast cancer-she was diagnosed with cancer 20 years ago and after successful treatment has been in remission ever since. She shared her gripping story, moving beyond the statistics and into defining her personal struggle and triumph, having undergone extensive chemotherapy and being prescribed numerous drugs along the way. "These drugs saved my life," she said, crediting innovative treatments like Adriamycin, Cyclophosphamide, Taxol, and Herceptin."
Sherry Knowles is a cancer survivor and former GlaxoSmithKline chief patent counsel who credits patented drugs with saving her life through treatments such as Adriamycin, Cyclophosphamide, Taxol, and Herceptin. Strong patent protection incentivizes drug developers to invest in discovery, clinical trials, and bringing medicines to market. Innovator companies face patent system challenges and downward pricing pressure from generic competition that can make important drugs unavailable. Pharmacy Benefit Managers (PBMs) can significantly raise patient costs through opaque pricing and formulary control. Policy choices and legislation on Capitol Hill influence incentives for innovation. Patents are portrayed as personal lifelines for patients and innovators alike.
Read at IPWatchdog.com | Patents & Intellectual Property Law
Unable to calculate read time
Collection
[
|
...
]